» Articles » PMID: 15180906

Coronavirus 3CLpro Proteinase Cleavage Sites: Possible Relevance to SARS Virus Pathology

Overview
Publisher Biomed Central
Specialty Biology
Date 2004 Jun 8
PMID 15180906
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the passing of more than a year since the first outbreak of Severe Acute Respiratory Syndrome (SARS), efficient counter-measures are still few and many believe that reappearance of SARS, or a similar disease caused by a coronavirus, is not unlikely. For other virus families like the picornaviruses it is known that pathology is related to proteolytic cleavage of host proteins by viral proteinases. Furthermore, several studies indicate that virus proliferation can be arrested using specific proteinase inhibitors supporting the belief that proteinases are indeed important during infection. Prompted by this, we set out to analyse and predict cleavage by the coronavirus main proteinase using computational methods.

Results: We retrieved sequence data on seven fully sequenced coronaviruses and identified the main 3CL proteinase cleavage sites in polyproteins using alignments. A neural network was trained to recognise the cleavage sites in the genomes obtaining a sensitivity of 87.0% and a specificity of 99.0%. Several proteins known to be cleaved by other viruses were submitted to prediction as well as proteins suspected relevant in coronavirus pathology. Cleavage sites were predicted in proteins such as the cystic fibrosis transmembrane conductance regulator (CFTR), transcription factors CREB-RP and OCT-1, and components of the ubiquitin pathway.

Conclusions: Our prediction method NetCorona predicts coronavirus cleavage sites with high specificity and several potential cleavage candidates were identified which might be important to elucidate coronavirus pathology. Furthermore, the method might assist in design of proteinase inhibitors for treatment of SARS and possible future diseases caused by coronaviruses. It is made available for public use at our website: http://www.cbs.dtu.dk/services/NetCorona/.

Citing Articles

HCoV-229E Mpro Suppresses RLR-Mediated Innate Immune Signalling Through Cleavage of NEMO and Through Other Mechanisms.

Martianez-Vendrell X, van Kasteren P, Myeni S, Kikkert M Int J Mol Sci. 2025; 26(3).

PMID: 39940968 PMC: 11818511. DOI: 10.3390/ijms26031197.


Human Coronavirus 229E Infection Inactivates Pyroptosis Executioner Gasdermin D but Ultimately Leads to Lytic Cell Death Partly Mediated by Gasdermin E.

Martianez-Vendrell X, Bloeme-Ter Horst J, Hutchinson R, Guy C, Bowie A, Kikkert M Viruses. 2024; 16(6).

PMID: 38932190 PMC: 11209299. DOI: 10.3390/v16060898.


Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection.

Samy A, Hassan A, M Hegazi N, Farid M, ElShafei M Sci Rep. 2024; 14(1):12059.

PMID: 38802394 PMC: 11130167. DOI: 10.1038/s41598-024-60721-3.


Deep profiling of potential substrate atlas of porcine epidemic diarrhea virus 3C-like protease.

Zhou J, Sun P, Wang Y, Qiu R, Yang Z, Guo J J Virol. 2024; 98(5):e0025324.

PMID: 38591878 PMC: 11092332. DOI: 10.1128/jvi.00253-24.


Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E.

Moatasim Y, Kutkat O, Osman A, Gomaa M, Okda F, Sayes M Microorganisms. 2023; 11(11).

PMID: 38004788 PMC: 10673013. DOI: 10.3390/microorganisms11112777.


References
1.
Thiel V, Ivanov K, Putics A, Hertzig T, Schelle B, Bayer S . Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol. 2003; 84(Pt 9):2305-2315. DOI: 10.1099/vir.0.19424-0. View

2.
Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr H . Treatment of SARS with human interferons. Lancet. 2003; 362(9380):293-4. PMC: 7112413. DOI: 10.1016/s0140-6736(03)13973-6. View

3.
Benson D, Karsch-Mizrachi I, Lipman D, Ostell J, Wheeler D . GenBank: update. Nucleic Acids Res. 2003; 32(Database issue):D23-6. PMC: 308779. DOI: 10.1093/nar/gkh045. View

4.
Berger A, Schechter I . Mapping the active site of papain with the aid of peptide substrates and inhibitors. Philos Trans R Soc Lond B Biol Sci. 1970; 257(813):249-64. DOI: 10.1098/rstb.1970.0024. View

5.
Matthews B . Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta. 1975; 405(2):442-51. DOI: 10.1016/0005-2795(75)90109-9. View